Xizang Haisco Pharmaceutical Group Co Ltd (002653 SHE) stock market data APIs
¥62.3508
0.14(0.2%)
as of September 11, 2026
Try our APIs with
free plan!
Xizang Haisco Pharmaceutical Group Co Ltd Financial Data Overview
Price chart is built with
Anychart
Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. It offers pharmaceutical products in the areas of anesthesia and analgesic, endocrine system, enteral parenteral nutrition, cardiovascular, psychiatric, tumor-related, digestive liver, and other diseases. Haisco Pharmaceutical Group Co., Ltd. has licensing and research collaboration with Eli Lilly and Company to develop medicines across multiple therapeutic areas. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2000 and is based in Shannan, China.
Prev. Close
62.3508
Open
62.4872
High
62.7066
Low
61.535
52 wk Range
41.8377-80.2049
Market Cap
71 408 M
P/E Ratio
73.6353
Shares Outstanding
1 141 M
Revenue
5 483 M
EPS
0.2649
Dividends (Yield)
0.0127
Beta
-0.213
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Xizang Haisco Pharmaceutical Group Co Ltd (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Xizang Haisco Pharmaceutical Group Co Ltd data using free add-ons & libraries
Get Xizang Haisco Pharmaceutical Group Co Ltd Fundamental Data
Xizang Haisco Pharmaceutical Group Co Ltd Fundamental data includes:
- Net Revenue: 5 483 M
- EBITDA: 1 125 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Xizang Haisco Pharmaceutical Group Co Ltd Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-27
- EPS/Forecast: NaN
Get Xizang Haisco Pharmaceutical Group Co Ltd End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Xizang Haisco Pharmaceutical Group Co Ltd News
New
AirNexis Therapeutics Announces that AN01, a Dual PDE3/4 Inhibitor Dry Powder Inhaler (DPI) Met its Primary Endpoint in a Phase 2b COPD Study (HSK39004-T1-202) Conducted in China by AirNexis' partner Haisco Pharmaceutical Group
AirNexis Therapeutics, Inc. Phase 2b dose ranging data presented at ERS show both doses of AN01 delivered significant and clinically relevant improvements in lung function versus placebo at Week 4 Tr...
Haisco and Nuvectis sign licensing deal for two drugs
Haisco Pharmaceutical Group has signed an exclusive licensing agreement granting US-based biotechnology company Nuvectis rights for two drug candidates in oncology and complement indications. Nuvecti...
Eli Lilly Expands Beyond Obesity With US$4b Vaccine And Genetic Bets
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Eli Lilly (NYSE:LLY) has agreed to acquire three vaccine an...
Eli Lilly Broadens Beyond Obesity Drugs With Vaccine And Genetic Bets
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Eli Lilly (NYSE:LLY) is pushing beyond its obesity drug f...
Get Xizang Haisco Pharmaceutical Group Co Ltd fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
